The COVID-19 pandemic arrived in Saudi Arabia at a time when demand for digestive remedies was already under pressure due to increasing awareness of healthy eating habits and lifestyle changes to avoid obesity, or at least maintain a healthy and manageable body weight. The official response to the COVID-19 pandemic intensified this pressure as obesity is widely known to be a key comorbidity factor in serious cases of COVID-19. Whilst COVID-19 is much less of a threat in 2022, the health concerns...
Euromonitor International's Digestive Remedies in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Digestive Remedies in Saudi Arabia
Euromonitor International
September 2022
List Of Contents And Tables
DIGESTIVE REMEDIES IN SAUDI ARABIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Value sales for digestive remedies decline as consumers adopt healthier lifestyles and the SFDA revises prices
Proton Pump Inhibitors continues to replace H2 Blockers
Pantozol overtakes Duspatalin to claim top position in digestive remedies
PROSPECTS AND OPPORTUNITIES
Probiotic supplements are expected to continue competing with digestive remedies
Julphar's re-emergence in Saudi Arabia expected to spur growth
E-commerce set to continue growing as consumers realise the convenience it offers
CATEGORY DATA
Table 1 Sales of Digestive Remedies by Category: Value 2017-2022
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN SAUDI ARABIA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources